DK1465602T3 - Matrix-filmtablet med kontrolleret frigivelse af naturlige blandinger af konjugerede östrogener - Google Patents

Matrix-filmtablet med kontrolleret frigivelse af naturlige blandinger af konjugerede östrogener

Info

Publication number: DK1465602T3
Authority: DK; Denmark
Prior art keywords: controlled release; matrix film; conjugated estrogens; natural mixtures; film tablet
Prior art date: 2001-12-14

Application number

DK02796612T

Other languages

English (en)

Inventor

Klaus Budde

Gerhard Kristen

Margit Wiards

Bernd Thumbeck

Original Assignee

Solvay Pharm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-14

Filing date

2002-12-12

Publication date

2009-09-28

2002-12-12 Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh

2009-09-28 Application granted granted Critical

2009-09-28 Publication of DK1465602T3 publication Critical patent/DK1465602T3/da

Links

229940035811 conjugated estrogen Drugs 0.000 title 1
238000013270 controlled release Methods 0.000 title 1
239000011159 matrix material Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

DK02796612T 2001-12-14 2002-12-12 Matrix-filmtablet med kontrolleret frigivelse af naturlige blandinger af konjugerede östrogener DK1465602T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01129830		2001-12-14
PCT/EP2002/014103 WO2003051336A1 (de)	2001-12-14	2002-12-12	Matrix-filmtablette mit kontrollierter freisetzung von natürlichen gemischen konjugierter oestrogene

Publications (1)

Publication Number	Publication Date
DK1465602T3 true DK1465602T3 (da)	2009-09-28

Family

ID=8179548

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02796612T DK1465602T3 (da)	2001-12-14	2002-12-12	Matrix-filmtablet med kontrolleret frigivelse af naturlige blandinger af konjugerede östrogener

Country Status (18)

Country	Link
US (1)	US8268351B2 (da)
EP (1)	EP1465602B1 (da)
JP (1)	JP4695837B2 (da)
CN (1)	CN100542538C (da)
AR (1)	AR037760A1 (da)
AT (1)	ATE438384T1 (da)
AU (1)	AU2002361396B2 (da)
BR (1)	BR0215044A (da)
CA (1)	CA2470207C (da)
DE (1)	DE50213751D1 (da)
DK (1)	DK1465602T3 (da)
ES (1)	ES2328910T3 (da)
MX (1)	MXPA04005769A (da)
PL (1)	PL205739B1 (da)
PT (1)	PT1465602E (da)
SI (1)	SI1465602T1 (da)
TW (1)	TWI252111B (da)
WO (1)	WO2003051336A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7303763B2 (en) *	2001-02-12	2007-12-04	Watson Laboratories, Inc.	Compositions for conjugated estrogens and associated methods
AU2003211146B2 (en) *	2002-02-21	2007-07-19	Valeant International (Barbados) Srl	Controlled release dosage forms
US8323692B2 (en)	2002-02-21	2012-12-04	Valeant International Bermuda	Controlled release dosage forms
US6992075B2 (en) *	2003-04-04	2006-01-31	Barr Laboratories, Inc.	C(14) estrogenic compounds
GB0329498D0 (en) *	2003-12-19	2004-01-28	Novartis Ag	Organic compounds
JP4521554B2 (ja) *	2004-03-31	2010-08-11	マイラン製薬株式会社	シクロスポリン製剤
DE102004035938A1 (de) *	2004-07-23	2006-02-16	Röhm GmbH & Co. KG	Verfahren zur Herstellung von überzogenen Arzneiformen mit stabilem Wirkstofffreigabeprofil
EP1679065A1 (en)	2005-01-07	2006-07-12	OctoPlus Sciences B.V.	Controlled release compositions for interferon based on PEGT/PBT block copolymers
JP5162141B2 (ja) *	2007-02-20	2013-03-13	エスエス製薬株式会社	フィルムコーティング用組成物
JP4864024B2 (ja) *	2008-02-15	2012-01-25	エスエス製薬株式会社	時限放出製剤
US20090232897A1 (en) *	2008-03-14	2009-09-17	Bijayananda Sahoo	Pharmaceutical compositions comprising conjugated estrogens

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3753767A (en) *	1971-08-02	1973-08-21	Colgate Palmolive Co	Method of sugar-coating tablets
DE3535536A1 (de) *	1985-10-04	1987-04-09	Lentia Gmbh	Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut
US5208225A (en) *	1986-02-27	1993-05-04	Warner-Lambert Company	Compositions containing fixed combinations
US5108995A (en) *	1987-09-24	1992-04-28	Jencap Research Ltd.	Hormone preparation and method
EP0322020A1 (en) *	1987-12-22	1989-06-28	Akzo N.V.	Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
HU9500322D0 (en) *	1994-02-08	1995-03-28	Solvay Deutschland	Process for separating estrogenes from the urine of mares with foal
US5458887A (en) *	1994-03-02	1995-10-17	Andrx Pharmaceuticals, Inc.	Controlled release tablet formulation
DE4429398C2 (de) *	1994-08-09	1997-09-11	Jenapharm Gmbh	Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
IE80467B1 (en) *	1995-07-03	1998-07-29	Elan Corp Plc	Controlled release formulations for poorly soluble drugs
WO1997004752A1 (en) *	1995-07-26	1997-02-13	Duramed Pharmaceuticals, Inc.	Pharmaceutical compositions of conjugated estrogens and methods for their use
DE19540253C2 (de) *	1995-10-28	1998-06-04	Jenapharm Gmbh	Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
CN1101682C (zh) *	1996-08-30	2003-02-19	索尔瓦药物有限公司	由牝马尿液获取雌激素的方法
PL185919B1 (pl)	1996-08-30	2003-08-29	Solvay Pharm Gmbh	Sposób otrzymywania estrogenów z moczu klaczySposób otrzymywania estrogenów z moczu klaczy
CN1101683C (zh) *	1996-08-30	2003-02-19	索尔瓦药物有限公司	由牝马尿获取雌激素的方法
SK281367B6 (sk)	1996-08-30	2001-02-12	Solvay Pharmaceuticals Gmbh	Spôsob získavania estrogénov z moču kobýl
ES2234139T3 (es) *	1997-08-11	2005-06-16	Alza Corporation	Forma de dosificacion de un agente activo de liberacion prolongada adaptada para la retencion gastrica.
US6022554A (en) *	1997-12-15	2000-02-08	American Home Products Corporation	Polymeric microporous film coated subcutaneous implant
DE19845358A1 (de) *	1998-10-02	2000-04-06	Roehm Gmbh	Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
ATE433318T1 (de) *	1999-02-10	2009-06-15	Pfizer Prod Inc	Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten
US6706283B1 (en) *	1999-02-10	2004-03-16	Pfizer Inc	Controlled release by extrusion of solid amorphous dispersions of drugs
US6632451B2 (en) *	1999-06-04	2003-10-14	Dexcel Pharma Technologies Ltd.	Delayed total release two pulse gastrointestinal drug delivery system
WO2000076478A1 (en) *	1999-06-14	2000-12-21	Cosmo S.P.A.	Controlled release and taste masking oral pharmaceutical compositions
US20010034340A1 (en) *	2000-03-20	2001-10-25	American Home Products Corporation	Hormone replacement therapy

2002
- 2002-11-29 TW TW091134751A patent/TWI252111B/zh not_active IP Right Cessation
- 2002-12-09 AR ARP020104765A patent/AR037760A1/es not_active Application Discontinuation
- 2002-12-12 AT AT02796612T patent/ATE438384T1/de active
- 2002-12-12 ES ES02796612T patent/ES2328910T3/es not_active Expired - Lifetime
- 2002-12-12 DE DE50213751T patent/DE50213751D1/de not_active Expired - Lifetime
- 2002-12-12 DK DK02796612T patent/DK1465602T3/da active
- 2002-12-12 EP EP02796612A patent/EP1465602B1/de not_active Expired - Lifetime
- 2002-12-12 PL PL369367A patent/PL205739B1/pl unknown
- 2002-12-12 CA CA2470207A patent/CA2470207C/en not_active Expired - Fee Related
- 2002-12-12 AU AU2002361396A patent/AU2002361396B2/en not_active Ceased
- 2002-12-12 WO PCT/EP2002/014103 patent/WO2003051336A1/de not_active Ceased
- 2002-12-12 SI SI200230848T patent/SI1465602T1/sl unknown
- 2002-12-12 BR BR0215044-1A patent/BR0215044A/pt active Search and Examination
- 2002-12-12 JP JP2003552269A patent/JP4695837B2/ja not_active Expired - Fee Related
- 2002-12-12 CN CNB028262034A patent/CN100542538C/zh not_active Expired - Fee Related
- 2002-12-12 PT PT02796612T patent/PT1465602E/pt unknown
- 2002-12-12 MX MXPA04005769A patent/MXPA04005769A/es active IP Right Grant
2004
- 2004-06-14 US US10/866,094 patent/US8268351B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AR037760A1 (es)	2004-12-01
US20050019408A1 (en)	2005-01-27
DE50213751D1 (de)	2009-09-17
WO2003051336A1 (de)	2003-06-26
CA2470207C (en)	2012-07-10
EP1465602A1 (de)	2004-10-13
JP2005513059A (ja)	2005-05-12
US8268351B2 (en)	2012-09-18
AU2002361396B2 (en)	2008-02-14
MXPA04005769A (es)	2004-09-10
PL369367A1 (en)	2005-04-18
JP4695837B2 (ja)	2011-06-08
AU2002361396A1 (en)	2003-06-30
CN100542538C (zh)	2009-09-23
CA2470207A1 (en)	2003-06-26
ES2328910T3 (es)	2009-11-19
ATE438384T1 (de)	2009-08-15
PL205739B1 (pl)	2010-05-31
BR0215044A (pt)	2004-11-03
TWI252111B (en)	2006-04-01
HK1075005A1 (zh)	2005-12-02
EP1465602B1 (de)	2009-08-05
SI1465602T1 (sl)	2009-12-31
CN1607943A (zh)	2005-04-20
TW200408414A (en)	2004-06-01
PT1465602E (pt)	2009-09-07

Publication	Publication Date	Title
ATE321531T1 (de)	2006-04-15	Atemerfrischender film
DK1108424T3 (da)	2005-10-03	Matrixtablet til langvarig frisætning af
DE60334274D1 (de)	2010-11-04	Polyacrylfilm formende zubereitungen
DE60029248D1 (de)	2006-08-17	Biaxial gestreckter bioabbaubarer film
DK1158992T3 (da)	2003-12-29	Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
DE60043447D1 (de)	2010-01-14	Zusammensetzungen mit kontrollierter freigabe enthaltend nimesulid
EP1411904A4 (en)	2006-06-07	PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE
DE60113638D1 (de)	2006-02-09	Elektro-lumineszente folie und diese verwendender schalter
ATE295503T1 (de)	2005-05-15	Stativ
DE60103582D1 (de)	2004-07-08	Zusammensetzungen mit kontrollierter Freisetzung
DE60027274D1 (de)	2006-05-24	Mikroporöser film
DE60206835D1 (de)	2005-12-01	Thermisch gesteuerter Entriegelungsmechanismus
DE60122229D1 (de)	2006-09-28	Trennfilm
DE60305728D1 (de)	2006-07-06	PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERLuNGERTER FREISETZUNG
ATE438384T1 (de)	2009-08-15	Matrix-filmtablette mit kontrollierter freisetzung von natürlichen gemischen konjugierter oestrogene
NO20044188L (no)	2004-12-03	Kontrollerte frigjoringsdoseformer
DE60120536D1 (de)	2006-07-27	Verbundfolie
DE60323018D1 (de)	2008-10-02	Silikonbeschichtungszusammensetzung und Trennfolie
DE50103586D1 (de)	2004-10-21	Fussheberorthese
DE50110136D1 (de)	2006-07-27	Stativ
ID28857A (id)	2001-07-12	Film kontrol matahari
DK1475379T3 (da)	2007-09-03	Anvendelse af scopinesterderivater til fremstilling af lægemidler
NO20031211D0 (no)	2003-03-17	Plaster omfattende diclofenac
DE60114822D1 (de)	2005-12-15	Pen-pet-pen-polymerfilm
DE50202530D1 (de)	2005-04-28	Release-Folie